1	The	the	DT	_	2	det	_
2	board	board	NN	_	6	nsubj	6:A0=PAG
3	of	of	IN	_	2	prep	_
4	AstraZeneca	astrazeneca	NNP	_	3	pobj	_
5	has	have	VBZ	_	6	aux	_
6	rejected	reject	VBN	pb=reject.01	0	root	_
7	the	the	DT	_	11	det	_
8	improved	improve	VBN	p2=JJ|pb=improve.01	11	amod	_
9	$	$	$	_	11	quantmod	_
10	119	0	CD	_	11	number	_
11	billion	#crd#	CD	_	6	dobj	6:A1=PPT;8:A1=PPT
12	(	(	-LRB-	_	14	punct	_
13	£70	£0	CD	p2=NN	14	number	_
14	billion	#crd#	CD	p2=NN	11	appos	_
15	)	)	-RRB-	_	11	punct	_
16	takeover	takeover	NN	_	17	nn	_
17	offer	offer	NN	p2=VBP	11	appos	_
18	from	from	IN	_	17	prep	_
19	US	us	NNP	_	20	nn	_
20	drugmaker	drugmaker	NN	p2=NNP	21	nn	_
21	Pfizer	pfizer	NNP	p2=NN	18	pobj	_
22	,	,	,	_	21	punct	_
23	a	a	DT	_	24	det	_
24	decision	decision	NN	_	21	appos	27:A0=CAU
25	that	that	WDT	_	27	nsubj	27:R-A0
26	has	have	VBZ	_	27	aux	_
27	caused	cause	VBN	pb=cause.01	24	rcmod	_
28	a	a	DT	_	30	det	_
29	sharp	sharp	JJ	_	30	amod	_
30	slide	slide	NN	_	27	dobj	27:A1=PPT
31	in	in	IN	_	30	prep	_
32	the	the	DT	_	34	det	_
33	UK	uk	NNP	_	34	nn	_
34	company	company	NN	_	37	poss	_
35	's	's	POS	_	34	possessive	_
36	share	share	NN	_	37	nn	_
37	price	price	NN	_	31	pobj	_
38	as	as	IN	_	41	mark	_
39	many	many	JJ	_	40	amod	_
40	investors	investor	NNS	_	41	nsubj	41:A0
41	think	think	VBP	pb=think.01	27	advcl	27:AM-ADV
42	it	it	PRP	_	44	nsubj	44:A0=PAG
43	effectively	effectively	RB	_	44	advmod	44:AM-MNR
44	brings	bring	VBZ	pb=bring.01	41	ccomp	41:A1=PPT
45	an	an	DT	_	46	det	_
46	end	end	NN	_	44	dobj	44:A1=PPT
47	to	to	IN	_	46	prep	_
48	the	the	DT	_	54	det	_
49	protracted	protract	VBN	p2=JJ|pb=protract.01	54	amod	_
50	and	and	CC	_	49	cc	_
51	increasingly	increasingly	RB	_	52	advmod	_
52	bitter	bitter	JJ	_	49	conj	_
53	takeover	takeover	NN	_	54	nn	_
54	saga	saga	NN	_	47	pobj	49:A1=PPT
55	.	.	.	_	6	punct	_

1	In	in	IN	_	10	prep	10:AM-LOC
2	a	a	DT	_	3	det	_
3	statement	statement	NN	_	1	pobj	_
4	on	on	IN	_	3	prep	_
5	Monday	monday	NNP	_	4	pobj	_
6	,	,	,	_	10	punct	_
7	AstraZeneca	astrazeneca	NNP	_	9	poss	_
8	's	's	POS	_	7	possessive	_
9	board	board	NN	_	10	nsubj	10:A0
10	said	say	VBD	pb=say.01	0	root	_
11	it	it	PRP	_	13	nsubj	13:A0=PAG
12	"	"	``	p2=''	13	punct	_
13	reiterates	reiterate	VBZ	pb=reiterate.01	10	ccomp	10:A1=PPT
14	its	its	PRP$	_	15	poss	_
15	confidence	confidence	NN	_	13	dobj	13:A1=PPT
16	in	in	IN	_	15	prep	_
17	AstraZeneca	astrazeneca	NNP	_	19	poss	_
18	's	's	POS	_	17	possessive	_
19	ability	ability	NN	_	16	pobj	_
20	to	to	TO	_	21	aux	_
21	deliver	deliver	VB	pb=deliver.01	19	infmod	_
22	on	on	IN	_	21	prep	21:A1=PPT
23	its	its	PRP$	_	24	poss	_
24	prospects	prospect	NNS	_	22	pobj	_
25	as	as	IN	_	24	prep	_
26	an	an	DT	_	31	det	_
27	independent	independent	NN	p2=JJ	30	npadvmod	_
28	,	,	,	_	30	punct	_
29	science	science	NN	_	30	nsubj	30:A0=PAG
30	led	lead	VBD	p2=VBN|pb=lead.02	31	amod	_
31	business	business	NN	_	25	pobj	30:A1=PPT
32	.	.	.	_	10	punct	_
33	"	"	''	_	10	punct	_

1	In	in	IN	_	8	prep	8:AM-ADV
2	response	response	NN	_	1	pobj	_
3	,	,	,	_	8	punct	_
4	Business	business	NNP	p2=NN	5	nn	_
5	Secretary	secretary	NNP	_	7	nn	_
6	Vince	vince	NNP	_	7	nn	_
7	Cable	cable	NNP	_	8	nsubj	8:A0
8	said	say	VBD	pb=say.01	0	root	_
9	:	:	:	_	8	punct	_
10	"	"	``	_	8	punct	_
11	I	I	PRP	_	14	nsubj	14:A0=PAG
12	'm	be	VBP	_	14	aux	_
13	not	not	RB	_	14	neg	14:AM-NEG
14	telling	tell	VBG	pb=tell.01	8	ccomp	8:A1=PPT
15	them	them	PRP	_	14	dobj	18:A0=PAG;14:A2=GOL
16	what	what	WP	p2=WDT	18	dobj	18:R-A1
17	to	to	TO	_	18	aux	_
18	do	do	VB	pb=do.02	14	xcomp	14:A1=PPT
19	,	,	,	_	23	punct	_
20	they	they	PRP	_	23	nsubj	23:A1=PPT
21	have	have	VBP	p2=VB	23	aux	_
22	clearly	clearly	RB	_	23	advmod	23:AM-MNR
23	come	come	VBN	p2=VB|pb=come.04	8	ccomp	_
24	to	to	IN	_	23	prep	23:A2=PRD
25	a	a	DT	_	27	det	_
26	firm	firm	JJ	_	27	amod	_
27	view	view	NN	_	24	pobj	_
28	on	on	IN	_	27	prep	_
29	the	the	DT	_	30	det	_
30	offer	offer	NN	_	28	pobj	34:A1=PPT
31	that	that	WDT	_	34	nsubjpass	34:R-A1
32	has	have	VBZ	_	34	aux	_
33	been	be	VBN	_	34	auxpass	_
34	put	put	VBN	pb=put.01	30	rcmod	_
35	to	to	IN	_	34	prep	34:A2=GOL
36	them	them	PRP	_	35	pobj	_
37	.	.	.	_	8	punct	_
38	"	"	''	_	8	punct	_

1	We	we	PRP	_	3	nsubj	3:A1=PPT
2	will	will	MD	_	3	aux	3:AM-MOD
3	stay	stay	VB	pb=stay.01	0	root	_
4	,	,	,	_	3	punct	_
5	as	as	IN	_	3	prep	3:A3
6	a	a	DT	_	7	det	_
7	Government	government	NNP	p2=NN	5	pobj	_
8	,	,	,	_	5	punct	_
9	very	very	RB	_	10	advmod	_
10	firmly	firmly	RB	_	11	advmod	_
11	in	in	IN	_	7	prep	_
12	a	a	DT	_	13	det	_
13	position	position	NN	_	11	pobj	_
14	of	of	IN	_	13	prep	_
15	keeping	keep	VBG	pb=keep.02	14	pcomp	_
16	our	our	PRP$	_	17	poss	_
17	options	option	NNS	_	15	dobj	15:A1=PPT
18	open	open	JJ	_	15	oprd	15:C-A1
19	.	.	.	_	3	punct	_

1	"	"	``	_	3	punct	_
2	We	we	PRP	_	3	nsubj	3:A0=PAG
3	have	have	VBP	p2=VB|pb=have.03	0	root	_
4	a	a	DT	_	6	det	_
5	clear	clear	JJ	_	6	amod	_
6	view	view	NN	_	3	dobj	3:A1=PPT
7	of	of	IN	_	6	prep	_
8	the	the	DT	_	10	det	_
9	national	national	JJ	_	10	amod	_
10	interest	interest	NN	_	7	pobj	_
11	in	in	IN	_	10	prep	_
12	protecting	protect	VBG	pb=protect.01	11	pcomp	_
13	research	research	NN	_	12	dobj	12:A1=PPT
14	and	and	CC	_	13	cc	_
15	development	development	NN	_	13	conj	_
16	,	,	,	_	13	punct	_
17	jobs	job	NNS	_	13	conj	_
18	and	and	CC	_	17	cc	_
19	manufacturing	manufacture	VBG	p2=NN|pb=manufacture.01	17	conj	_
20	here	here	RB	_	19	advmod	19:AM-LOC
21	,	,	,	_	3	punct	_
22	and	and	CC	_	3	cc	_
23	we	we	PRP	_	25	nsubj	25:A0=PAG
24	have	have	VBP	_	25	aux	_
25	sent	send	VBN	pb=send.01	3	conj	_
26	out	out	RP	_	25	prt	25:AM-DIR
27	that	that	DT	p2=IN	28	det	_
28	message	message	NN	_	25	dobj	25:A1=PPT
29	loud	loud	JJ	_	28	amod	_
30	and	and	CC	_	29	cc	_
31	clear	clear	JJ	_	29	conj	_
32	.	.	.	_	25	punct	_
33	"	"	''	_	25	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nn	_
2	Inc	inc	NNP	_	0	root	_
3	.	.	.	_	2	punct	_

1	,	,	,	_	16	punct	_
2	which	which	WDT	_	3	nsubj	3:R-A1
3	is	be	VBZ	pb=be.01	0	root	_
4	the	the	DT	_	5	det	_
5	world	world	NN	_	10	poss	_
6	's	's	POS	_	5	possessive	_
7	second	#ord#	RB	_	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	biggest	big	JJS	p2=RBS	10	amod	_
10	drugmaker	drugmaker	NN	_	3	attr	3:A2=PRD
11	by	by	IN	_	10	prep	_
12	revenue	revenue	NN	_	11	pobj	_
13	,	,	,	_	16	punct	_
14	has	have	VBZ	_	16	aux	_
15	been	be	VBN	_	16	aux	_
16	courting	court	VBG	pb=court.01	0	root	_
17	AstraZeneca	astrazeneca	NNP	_	18	nn	_
18	PLC	plc	NNP	_	16	dobj	16:A1=COM
19	since	since	IN	_	16	prep	16:AM-TMP
20	January	january	NNP	_	19	pobj	_
21	,	,	,	_	16	punct	_
22	arguing	argue	VBG	pb=argue.01	16	advcl	16:AM-ADV
23	that	that	IN	_	26	complm	_
24	their	their	PRP$	_	25	poss	_
25	businesses	business	NNS	_	26	nsubj	26:A1=PPT;30:A1=PPT
26	are	be	VBP	pb=be.01	22	ccomp	22:A1=PPT
27	complementary	complementary	JJ	_	26	acomp	26:A2=PRD
28	and	and	CC	_	26	cc	_
29	would	would	MD	_	30	aux	30:AM-MOD
30	be	be	VB	pb=be.01	26	conj	_
31	stronger	strong	JJR	p2=RBR	30	acomp	30:A2=PRD
32	together	together	RB	_	30	advmod	30:AM-MNR
33	.	.	.	_	16	punct	_

